UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS. Guest User 14/03/2026 Guest User 14/03/2026 Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland Read More Guest User 14/03/2026 Guest User 14/03/2026 Vigilance state dissociation induced by 5-MeO-DMT in mice Read More Guest User 14/03/2026 Guest User 14/03/2026 Serotonergic psychedelics as epigenetic modulators: A paradigm shift in Alzheimer's disease therapeutics Read More Guest User 14/03/2026 Guest User 14/03/2026 Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine Read More Guest User 08/03/2026 Guest User 08/03/2026 An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice Read More Guest User 08/03/2026 Guest User 08/03/2026 N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain Read More Guest User 08/03/2026 Guest User 08/03/2026 Ketamine attenuates the effects of intermittent social defeat on anxiety, social interaction and cocaine-induced conditioned place preference in male mice Read More Guest User 08/03/2026 Guest User 08/03/2026 Pilot study of psilocybin in patients with post-treatment lyme disease Read More Guest User 01/03/2026 Guest User 01/03/2026 Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD A Randomized Clinical Trial Read More Guest User 01/03/2026 Guest User 01/03/2026 Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration Read More Guest User 01/03/2026 Guest User 01/03/2026 The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial Read More Guest User 01/03/2026 Guest User 01/03/2026 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression Read More Guest User 22/02/2026 Guest User 22/02/2026 Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model Read More Guest User 22/02/2026 Guest User 22/02/2026 Lifetime MDMA use and associations with meaning in life in the context of childhood trauma Read More Guest User 22/02/2026 Guest User 22/02/2026 Trip sitting or just sitting? Acute psychedelic experiences vary little between session facilitators in healthy trials but substantially in clinical ones. Read More Guest User 22/02/2026 Guest User 22/02/2026 Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression Read More Guest User 14/02/2026 Guest User 14/02/2026 The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials Read More Guest User 14/02/2026 Guest User 14/02/2026 Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders Read More Guest User 14/02/2026 Guest User 14/02/2026 Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence Read More Guest User 14/02/2026 Guest User 14/02/2026 Ayahuasca Enhances Functional Connectivity in the Third Visual Pathway and Mirror Neuron Networks: a Crossover, Multiple-Dose fMRI Study Read More Newer Posts Older Posts
Guest User 14/03/2026 Guest User 14/03/2026 Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland Read More
Guest User 14/03/2026 Guest User 14/03/2026 Vigilance state dissociation induced by 5-MeO-DMT in mice Read More
Guest User 14/03/2026 Guest User 14/03/2026 Serotonergic psychedelics as epigenetic modulators: A paradigm shift in Alzheimer's disease therapeutics Read More
Guest User 14/03/2026 Guest User 14/03/2026 Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine Read More
Guest User 08/03/2026 Guest User 08/03/2026 An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice Read More
Guest User 08/03/2026 Guest User 08/03/2026 N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain Read More
Guest User 08/03/2026 Guest User 08/03/2026 Ketamine attenuates the effects of intermittent social defeat on anxiety, social interaction and cocaine-induced conditioned place preference in male mice Read More
Guest User 08/03/2026 Guest User 08/03/2026 Pilot study of psilocybin in patients with post-treatment lyme disease Read More
Guest User 01/03/2026 Guest User 01/03/2026 Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD A Randomized Clinical Trial Read More
Guest User 01/03/2026 Guest User 01/03/2026 Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration Read More
Guest User 01/03/2026 Guest User 01/03/2026 The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial Read More
Guest User 01/03/2026 Guest User 01/03/2026 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression Read More
Guest User 22/02/2026 Guest User 22/02/2026 Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model Read More
Guest User 22/02/2026 Guest User 22/02/2026 Lifetime MDMA use and associations with meaning in life in the context of childhood trauma Read More
Guest User 22/02/2026 Guest User 22/02/2026 Trip sitting or just sitting? Acute psychedelic experiences vary little between session facilitators in healthy trials but substantially in clinical ones. Read More
Guest User 22/02/2026 Guest User 22/02/2026 Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression Read More
Guest User 14/02/2026 Guest User 14/02/2026 The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials Read More
Guest User 14/02/2026 Guest User 14/02/2026 Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders Read More
Guest User 14/02/2026 Guest User 14/02/2026 Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence Read More
Guest User 14/02/2026 Guest User 14/02/2026 Ayahuasca Enhances Functional Connectivity in the Third Visual Pathway and Mirror Neuron Networks: a Crossover, Multiple-Dose fMRI Study Read More
